Category

Cohort News

Prenosis Announces $20M BARDA Contract and $20M Series A Financing Round, Advancing Mission to Deliver Integrated Diagnostics and Therapeutics

//
Categories
Latest fundraising efforts accelerate further innovation in biology-based diagnostics and therapeutics for critical care conditions CHICAGO, IL – January 29, 2026 – Prenosis, a biology-based technology company delivering integrated diagnostics and therapeutics, announced today two major milestones: completion of its...
Read More →